L04AA13 • leflunomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Leflunomide is a medication used for the treatment of rheumatoid arthritis and psoriatic arthritis. It works by inhibiting pyrimidine synthesis, thereby reducing inflammation and autoimmune responses.
The medication is taken orally, usually once daily, and the dose is adjusted based on the patient's response. Monitoring of liver and hematologic function is important during treatment.
Side effects may include nausea, diarrhea, hair loss, or elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or pancytopenia may occur.
Leflunomide is not recommended for pregnant women or those planning to become pregnant, as well as patients with severe liver impairment or hypersensitivity to this medication.
Substance: leflunomide
Date of last drug list: 10-04-2026
Commercial code: W69618005
Concentration: 20mg
Pharmaceutical form: film-coated tablets
Quantity: 30
Product type: generic
Price: 87.08 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: HAUPT PHARMA MUNSTER GMBH - GERMANIA
Holder: SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA
Number: 8581/2016/05
Shelf life: 3 years
G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis
Price
Copayment
Patient
87.08 RON
87.08 RON
0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
87.08 RON
87.08 RON
0.00 RON